Skip to main content
Clinical Trials/NCT04719546
NCT04719546
Completed
Not Applicable

Identifying Risk Factors of Necrotizing Enterocolitis in the NICU of Nancy Benchmarking With the NICU of Lyon Over 10 Years

Central Hospital, Nancy, France2 sites in 1 country459 target enrollmentJanuary 21, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Necrotizing Enterocolitis of Newborn
Sponsor
Central Hospital, Nancy, France
Enrollment
459
Locations
2
Primary Endpoint
Necrotizing enterocolitis (NEC)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

With premature newborn increase survival, the risk of serious neonatal morbidity, such as necrotizing enterocolitis (NEC), also increased. NEC affects between 2 to 7% of premature infants including 5 to 22% of newborns weighing less than 1000 g.

NEC is an acquired disease, caused by inflammation of the intestinal lining. It is the most common life-threatening gastrointestinal emergency of prematurity, associated with a significant morbidity and mortality.

The etiology and physiopathology are multifactorial, complex, and remain poorly understood. The mechanism of the lesions seems to involve factors including immaturity of the intestinal barrier and the immune system, microvascular imbalance, disturbed gut flora and systemic inflammation.

Despite improved knowledge about this disease, the proportion of surviving patients has not improved for several years. It frequently leads to long-term sequelae depending on the severity of the NEC and its treatment.

Early diagnosis and early treatment of NEC may reduce the risk of mortality and morbidity. The aim of this retrospective bi-centric study is to look for risk factors allowing the prediction of NEC in order to prevent and improve the early management of this disease.

Registry
clinicaltrials.gov
Start Date
January 21, 2021
End Date
August 31, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Central Hospital, Nancy, France
Responsible Party
Principal Investigator
Principal Investigator

Jean-Michel HASCOET

Professor

Central Hospital, Nancy, France

Eligibility Criteria

Inclusion Criteria

  • Premature newborns (\< 37 weeks of gestation) having done a necrotizing enterocolitis stage II or III according to Bell's criteria.

Exclusion Criteria

  • Children term born (\> 37 weeks of gestation)
  • Necrotizing enterocolitis during an hospitalisation outside the NICU of Nancy or Lyon
  • Malformation or pre-existing digestive pathology
  • Complex or severe malformative pathologies

Outcomes

Primary Outcomes

Necrotizing enterocolitis (NEC)

Time Frame: 10 years

Number of infants with NEC at a Bell stage \> 1 in Nancy as compared to Lyon

Risk factor of NEC during Pregnancy

Time Frame: 10 years

Number of infants who had abnormal pregnancy course in each group (defined as the presence of multiple pregnancy; gestational hypertension; Intrauterine Growth Retardation defined as a birth weight below the 10th Centile of Fenton Curves; Abnormal heart rate at the time of delivery)

Gestational age of infants with NEC

Time Frame: 10 years

Gestational age in weeks of infants presenting with NEC in Nancy as compared to Lyon

Secondary Outcomes

  • Red Blood Cell transfusion(10 years)
  • Perinatal risk factor of NEC(10 years)
  • NEC occurrence(10 years)
  • Gender(10 years)
  • Place of birth as risk factor for NEC(10 years)
  • Asphyxia at birth(10 years)
  • Patent Ductus Arteriosus (PDA)(10 years)
  • Feeding(10 years)
  • Infection(10 years)

Study Sites (2)

Loading locations...

Similar Trials